Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the ...

FDA Device Recall #Z-1084-2026 — Class II — December 15, 2025

Recall Summary

Recall Number Z-1084-2026
Classification Class II — Moderate risk
Date Initiated December 15, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Diagnostica Stago, Inc.
Location Parsippany, NJ
Product Type Devices
Quantity 438 units

Product Description

Asserachrom HPIA. Model/Catalog Number: 00615. The Asserachrom HPIA kit is intended for the qualitative detection in plasma or serum of the anti-heparin-platelet factor 4 (PF4) antibodies generated during the type II heparin-induced thrombocytopenia (HIT type II) by ELISA.

Reason for Recall

Potential for defect for Asserachrom HPIA lot 271288, which can affect every well in the impacted strip and produce negative results.

Distribution Pattern

Worldwide - US Nationwide distribution in the states of AL, CA, FL, GA, HI, IA, MA, MI, NJ, NV, NY, OH, TN, WI and the countries of Belgium, Canada, Denmark, Algeria, Spain, Finland, France, Great Britain, Italy, Lebanon, Saudi Arabia, Uganda.

Lot / Code Information

Reference Number: 00615. UDI: (01)03607450006155(11)240531(17)260531(10)271288(241)00615. Lot Number: 271288.

Other Recalls from Diagnostica Stago, Inc.

Recall # Classification Product Date
Z-1585-2026 Class II Brand Name: STA Liatest D-Di Product Name: STA... Feb 5, 2026
Z-1491-2026 Class II Brand Name: STA Liatest Free Protein S Product... Feb 4, 2026
Z-0205-2026 Class II Product: STA Liatest D-Di; REF: 00515; Sep 12, 2025
Z-2473-2025 Class II STA Satellite. Product Code: All references. Al... Jul 21, 2025
Z-2474-2025 Class II STA-Liquid Anti-Xa 4. Model/Catalog Number: 003... Jul 21, 2025

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.